Alto Neuroscience, Inc. (ANRO)
24.03
+0.51
(+2.17%)
USD |
NYSE |
Oct 08, 16:00
24.02
-0.01
(-0.04%)
Pre-Market: 20:00
Alto Neuroscience Market Cap : 843.31M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 843.31M |
| October 07, 2026 | 825.41M |
| October 06, 2026 | 831.37M |
| October 05, 2026 | 842.60M |
| October 02, 2026 | 870.33M |
| October 01, 2026 | 888.23M |
| September 30, 2026 | 895.95M |
| September 29, 2026 | 932.80M |
| September 28, 2026 | 935.60M |
| September 25, 2026 | 929.64M |
| September 24, 2026 | 953.85M |
| September 23, 2026 | 965.08M |
| September 22, 2026 | 1.080B |
| September 21, 2026 | 1.075B |
| September 18, 2026 | 1.062B |
| September 17, 2026 | 1.087B |
| September 16, 2026 | 1.053B |
| September 15, 2026 | 1.062B |
| September 14, 2026 | 1.112B |
| September 11, 2026 | 1.123B |
| September 10, 2026 | 1.112B |
| September 09, 2026 | 1.196B |
| September 08, 2026 | 1.257B |
| September 04, 2026 | 1.248B |
| September 03, 2026 | 1.277B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.286B |
| September 01, 2026 | 1.235B |
| August 31, 2026 | 1.242B |
| August 28, 2026 | 1.233B |
| August 27, 2026 | 1.274B |
| August 26, 2026 | 1.282B |
| August 25, 2026 | 1.274B |
| August 24, 2026 | 1.272B |
| August 21, 2026 | 1.203B |
| August 20, 2026 | 1.202B |
| August 19, 2026 | 1.224B |
| August 18, 2026 | 1.198B |
| August 17, 2026 | 1.179B |
| August 14, 2026 | 1.128B |
| August 13, 2026 | 1.134B |
| August 12, 2026 | 1.024B |
| August 11, 2026 | 1.010B |
| August 10, 2026 | 992.81M |
| August 07, 2026 | 1.005B |
| August 06, 2026 | 997.95M |
| August 05, 2026 | 982.53M |
| August 04, 2026 | 989.54M |
| August 03, 2026 | 955.89M |
| July 31, 2026 | 948.88M |
| July 30, 2026 | 1.004B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.654B |
| Corcept Therapeutics, Inc. | 12.79B |
| Veru, Inc. | 41.26M |
| Johnson & Johnson | 617.66B |
| Eli Lilly & Co. | 1.101T |
Market Cap Related Metrics
| PEG Ratio | -3.199 |
| Price to Book Value | 3.846 |
| Price | 24.03 |
| Earnings Yield | -10.29% |
| PEGY Ratio | -3.199 |